Delivery Order SPE2DB20D1100-SPE2DB24FA5V9
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,797.84 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the provision of IBRANCE 75 MG CAPSULE 21S pharmaceutical products and has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which does not have a set-aside designation. This delivery order is part of a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,792.08 firm fixed-price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract (SPE2DX15D3404|SPE2DX24F1ASP) by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $7,792.08 contract is for the delivery of Ibrance 125 mg Capsule 21s, a pharmaceutical product. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and DLA, which serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The award, valued at $7,792.08, has a completion date of February 16, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distributor. The order, valued at $7,792.08, is for the supply of 125 mg Ibrance capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $7,490.17 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide IBRANCE 75 MG CAPSULE 21S. The order is to be performed in Conshohocken, Pennsylvania over a period of approximately one month, from September 29, 2023 through October 23, 2023. As the prime contractor, Amerisourcebergen will fulfill the order without the involvement of major...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $14,980 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 21 capsules of IBRANCE 75 MG CAPSULE. The order was awarded on November 2, 2023 under an existing indefinite delivery contract with no set-aside designation specified. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 27, 2023. As a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $8,067.35, and has an ultimate completion date of January 17, 2025. The contract covers the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,248,339 units of IBRANCE 100 MG CAPSULE 21S. The $14,977.62 contract has a performance period through January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously supplied pharmaceuticals, medical supplies, and distribution services to DLA under multiple awards. This latest...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $127,289.53 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply IBRANCE 125 MG CAPSULE 21S. Performance will take place in Conshohocken, Pennsylvania over a period of approximately six weeks concluding in early September. The contract calls for Amerisourcebergen to deliver pharmaceutical products in support of DLA's medical supply chain...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA5V9Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a $15,595.70 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a completion date of March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 3/6/24 |